poisar

Stocks · News reference

RBC Capital Reiterates Sector Perform on Penumbra, Maintains $374 Price Target

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

PEN
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Incuvate Files Patent Infringement Lawsuit Against Penumbra

    Incuvate has filed a patent-infringement lawsuit against Penumbra in U.S. District Court for the Northern District of California, alleging that Penumbra's THUNDERBOLT Neurovascular Thrombectomy System and related components infringe five Incuvate patents covering real-time aspiration monitoring technology. Incuvate is seeking damages, injunctive relief, and other remedies.

    PEN
  3. SEC EDGAR

    8-K filing — Penumbra Inc (PEN)

    Filed: 2026-07-30 AccNo: 0001321732-26-000036 Size: 474 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

    PEN